ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,815Medicare Part D Prescriptions Filled, Including Refills

Rank: 594 out of 2170

$527K Total Retail Price of All Prescriptions

Rank: 410 out of 2170

109 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

3% of this provider’s 5,377 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

72 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
SIMVASTATIN 427 328 1 1
DIVALPROEX SODIUM 307 196 2 91
HALOPERIDOL 249 151 3 176
AMLODIPINE BESYLATE 246 230 4 4
OLANZAPINE 229 132 5 139
OMEPRAZOLE 195 153 6 2
QUETIAPINE FUMARATE 194 150 7 88
FAMOTIDINE 193 122 8 96
LEVOTHYROXINE SODIUM 193 140 8 5
METOPROLOL TARTRATE 185 137 10 10
BENZTROPINE MESYLATE 181 137 R 11 172
RISPERIDONE 174 128 12 73
DONEPEZIL HCL 170 160 13 32
METFORMIN HCL 156 73 14 8
CITALOPRAM HBR 155 119 15 19
TRAZODONE HCL 148 68 16 38
TAMSULOSIN HCL 141 108 17 33
FUROSEMIDE 133 97 18 6
ENULOSE 130 63 19 273
LANTUS 121 75 20 51
LISINOPRIL 121 100 20 3
CLOZAPINE 116 65 22 284
GABAPENTIN 110 79 23 14
NAMENDA 107 94 24 48
IBUPROFEN 105 77 25 105
POTASSIUM CHLORIDE 93 79 26 16
SERTRALINE HCL 85 85 27 25
MIRTAZAPINE 83 54 28 46
CLONIDINE HCL 82 77 29 54
LAMOTRIGINE 81 34 30 136
METOPROLOL SUCCINATE 78 42 31 13
LEVETIRACETAM 71 34 32 109
PHENYTOIN SODIUM EXTENDED 70 30 33 142
LOSARTAN POTASSIUM 66 52 34 21
VALPROIC ACID 63 31 35 222
INVEGA SUSTENNA 62 53 36 393
LITHIUM CARBONATE 62 31 36 329
GLIMEPIRIDE 62 34 36 31
SPIRONOLACTONE 61 47 39 71
LACTULOSE 61 28 39 125
TERAZOSIN HCL 59 59 41 156
ATENOLOL 56 18 42 23
CARBAMAZEPINE 54 37 43 204
CARVEDILOL 53 45 44 26
CLOPIDOGREL 52 45 45 37
HYDROCHLOROTHIAZIDE 51 51 46 9
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.